Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Feb;67(2):419–429. doi: 10.1172/JCI110050

Clearance of Immunoreactive Somatostatin by Perfused Rat Liver

Harold Sacks 1,2, L Cass Terry 1,2
PMCID: PMC370583  PMID: 6109737

Abstract

Other investigators have demonstrated that concentrations of immunoreactive somatostatin (IRS) are higher in blood from the hepatic portal vein or its tributaries than in blood from the hepatic or peripheral systemic veins of man and animals. This suggests that there is hepatic extraction of IRS from the portal system in vivo. In the rat, portal vein plasma IRS is reported to be heterogeneous and to contain, in part, a 1,600 mol wt form of IRS which is immunochemically similar to synthetic somatostatin and not significantly bound to high molecular weight plasma protein. Our study was undertaken to determine directly whether unbound synthetic cyclic somatostatin was cleared by the rat liver perfused through the hepatic portal vein in vitro with a recirculating, plasma-free, erythrocyte-containing perfusate.

At 37°C and pH 7.40, perfusate IRS, at initial concentrations (1,728 pg/ml) within the range previously reported in rat portal venous blood, was removed by the liver at a rate commensurate with first-order kinetics. Hepatic clearance was 0.84±0.04 ml/min per g postperfusion wet weight (SE). Hepatic extraction was 36±2%, and t½ was 20.0±1.3 min. Recovery of IRS from the perfusate without the liver was >85%, excluding significant degradation by the medium. Clearance, extraction, and t½ of IRS were not changed by an unphysiologic IRS concentration (621,500 pg/ml), or by pharmacologic concentrations of insulin (8.2 μM) or glucagon (2.9 μM).

The t½ was prolonged significantly to 28.2±1.9 and 45.6±4.7 min during perfusions at liver temperatures of 25° and 16°C, respectively. At 37°C, the t½ was also significantly increased to 28.7±3.2 and 24.2±1.1 min at perfusate pH 7.06 and 6.78, respectively.

These studies indicate that the rat liver clears unbound IRS from the perfusate by a first-order kinetic process that is (a) unsaturable at pharmacologic concentrations, (b) temperature-sensitive and, to a lesser extent, influenced by lowered pH, and (c) not affected by insulin and glucagon. The liver would appear to play an important role in the metabolism of the 1,600 mol wt form of somatostatin. Clearance of endogenous IRS by the liver should be considered in the interpretation of IRS concentrations in the peripheral systemic veins.

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Lundqvist G., Rothman J., Chang R., Fernandez-Durango R., Elde R., Coy D. H., Schally A. V., Meyers C. Radioimmunoassay of somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1139–1144. doi: 10.1016/0026-0495(78)90032-x. [DOI] [PubMed] [Google Scholar]
  2. Bhathena S. J., Voyles N. R., Smith S., Recant L. Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. J Clin Invest. 1978 Jun;61(6):1488–1497. doi: 10.1172/JCI109069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Canterbury J. M., Bricker L. A., Levey G. S., Kozlovskis P. L., Ruiz E., Zull J. E., Reiss E. Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest. 1975 Jun;55(6):1245–1253. doi: 10.1172/JCI108043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cherrington A. D., Caldwell M. D., Dietz M. R., Exton J. H., Crofford O. B. The effect of somatostatin on glucose uptake and production by rat tissues in vitro. Diabetes. 1977 Aug;26(8):740–748. doi: 10.2337/diab.26.8.740. [DOI] [PubMed] [Google Scholar]
  5. Chideckel E. W., Palmer J., Koerker D. J., Ensinck J., Davidson M. B., Goodner C. J. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J Clin Invest. 1975 Apr;55(4):754–762. doi: 10.1172/JCI107986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conlon J. M., Srikant C. B., Ipp E., Schusdziarra V., Vale W., Unger R. H. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma. J Clin Invest. 1978 Dec;62(6):1187–1193. doi: 10.1172/JCI109238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duckworth W. C., Kitabchi A. E. Insulin and glucagon degradation by the same enzyme. Diabetes. 1974 Jun;23(6):536–543. doi: 10.2337/diab.23.6.536. [DOI] [PubMed] [Google Scholar]
  8. Exton J. H. The perfused rat liver. Methods Enzymol. 1975;39:25–36. doi: 10.1016/s0076-6879(75)39006-x. [DOI] [PubMed] [Google Scholar]
  9. Fitz-Patrick D., Patel Y. C. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid. J Clin Invest. 1979 Sep;64(3):737–742. doi: 10.1172/JCI109517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gustavsson S., Lundqvist G. Inhibition of pancreatic somatostatin release in response to glucose. Biochem Biophys Res Commun. 1978 Jun 29;82(4):1229–1235. doi: 10.1016/0006-291x(78)90319-4. [DOI] [PubMed] [Google Scholar]
  11. Hems R., Ross B. D., Berry M. N., Krebs H. A. Gluconeogenesis in the perfused rat liver. Biochem J. 1966 Nov;101(2):284–292. doi: 10.1042/bj1010284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ipp E., Dobbs R. E., Arimura A., Vale W., Harris V., Unger R. H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ishida T., Röjdmark S., Bloom G., Chou M. C., Field J. B. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog. Endocrinology. 1980 Jan;106(1):220–230. doi: 10.1210/endo-106-1-220. [DOI] [PubMed] [Google Scholar]
  14. Jaspan J. B., Huen A. H., Morley C. G., Moossa A. R., Rubenstein A. H. The role of the liver in glucagon metabolism. J Clin Invest. 1977 Aug;60(2):421–428. doi: 10.1172/JCI108791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jaspan J., Polonsky K., Lewis M., Moossa A. R. Reduction in portal vein blood flow by somatostatin. Diabetes. 1979 Oct;28(10):888–892. doi: 10.2337/diab.28.10.888. [DOI] [PubMed] [Google Scholar]
  16. Kaden M., Harding P., Field J. B. Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. J Clin Invest. 1973 Aug;52(8):2016–2028. doi: 10.1172/JCI107386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kitabchi A. E., Duckworth W. C., Brush J. S., Heinemann M. Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme. J Clin Invest. 1971 Sep;50(9):1792–1799. doi: 10.1172/JCI106669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Krejs G. J., Orci L., Conlon J. M., Ravazzola M., Davis G. R., Raskin P., Collins S. M., McCarthy D. M., Baetens D., Rubenstein A. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med. 1979 Aug 9;301(6):285–292. doi: 10.1056/NEJM197908093010601. [DOI] [PubMed] [Google Scholar]
  19. Kronheim S., Berelowitz M., Pimstone B. L. The characterization of somatostatin-like immunoreactivity in human serum. Diabetes. 1978 May;27(5):523–529. doi: 10.2337/diab.27.5.523. [DOI] [PubMed] [Google Scholar]
  20. MORTIMORE G. E., TIETZE F., STETTEN D., Jr Metabolism of insulin-I 131; studies in isolated, perfused rat liver and hindlimb preparations. Diabetes. 1959 Jul-Aug;8(4):307–314. doi: 10.2337/diab.8.4.307. [DOI] [PubMed] [Google Scholar]
  21. Marks N., Stern F. Inactivation of somatostatin (GH-RIH) and its an analogs by crude and partially purified rat brain extracts. FEBS Lett. 1975 Jul 15;55(1):220–224. doi: 10.1016/0014-5793(75)80996-3. [DOI] [PubMed] [Google Scholar]
  22. Ogawa N., Thompson T., Friesen H. G., Martin J. B., Brazeau P. Properties of soluble somatostatin-binding protein. Biochem J. 1977 Aug 1;165(2):269–277. doi: 10.1042/bj1650269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Oliver J. R., Long K., Wagle S. R., Allen D. O. Somatostatin inhibition of glucagon-stimulated adenosine 3'-5'-monophosphate accumulation in isolated hepatocytes. Proc Soc Exp Biol Med. 1976 Nov;153(2):367–369. doi: 10.3181/00379727-153-39547. [DOI] [PubMed] [Google Scholar]
  24. Oliver J. R., Wagle S. R. Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of langerhans and isolated hepatocytes. Biochem Biophys Res Commun. 1975 Feb 3;62(3):772–777. doi: 10.1016/0006-291x(75)90466-0. [DOI] [PubMed] [Google Scholar]
  25. Patel Y. C., Wheatley T., Fitz-Patrick D., Brock G. A sensitive radioimmunoassay for immunoreactive somatostatin in extracted plasma: measurement and characterization of portal and peripheral plasma in the rat. Endocrinology. 1980 Jul;107(1):306–313. doi: 10.1210/endo-107-1-306. [DOI] [PubMed] [Google Scholar]
  26. Penman E., Wass J. A., Lund A., Lowry P. J., Stewart J., Dawson A. M., Besser G. M., Rees L. H. Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem. 1979 Jan;16(1):15–25. doi: 10.1177/000456327901600103. [DOI] [PubMed] [Google Scholar]
  27. Pipeleers D., Somers G., Gepts W., De Nutte N., De Vroede M. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications. J Clin Endocrinol Metab. 1979 Oct;49(4):572–579. doi: 10.1210/jcem-49-4-572. [DOI] [PubMed] [Google Scholar]
  28. ROBIN E. D., WILSON R. J., BROMBERG P. A. Intracellular acidbase relations and intracellular buffers. Ann N Y Acad Sci. 1961 Jun 17;92:539–546. doi: 10.1111/j.1749-6632.1961.tb45004.x. [DOI] [PubMed] [Google Scholar]
  29. Rorstad O. P., Epelbaum J., Brazeau P., Martin J. B. Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology. 1979 Nov;105(5):1083–1092. doi: 10.1210/endo-105-5-1083. [DOI] [PubMed] [Google Scholar]
  30. Rubenstein A. H., Pottenger L. A., Mako M., Getz G. S., Steiner D. F. The metabolism of proinsulin and insulin by the liver. J Clin Invest. 1972 Apr;51(4):912–921. doi: 10.1172/JCI106886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sacks H., Grant B. J., Vinik A. I. Metabolism of synthetic human heptadecapeptide gastrin by the isolated perfused rat liver. S Afr Med J. 1978 Feb 18;53(7):249–251. [PubMed] [Google Scholar]
  32. Sacks H., Pimstone B., Waligora K., Peires L., Weinkove E., Saunders S. Differences between insulin degradation by soluble fractions and insulin clearance by perfused livers of normal, protein-depleted, and starved rats. Diabetes. 1977 Oct;26(10):956–966. doi: 10.2337/diab.26.10.956. [DOI] [PubMed] [Google Scholar]
  33. Sacks H., Waligora K., Matthews J., Pimstone B. Inhibition by somatostatin of glucagon-induced glucose release from the isolated perfused rat liver. Endocrinology. 1977 Dec;101(6):1751–1759. doi: 10.1210/endo-101-6-1751. [DOI] [PubMed] [Google Scholar]
  34. Schusdziarra V., Harris V., Conlon J. M., Arimura A., Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest. 1978 Sep;62(3):509–518. doi: 10.1172/JCI109154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schusdziarra V., Zyznar E., Rouiller D., Boden G., Brown J. C., Arimura A., Unger R. H. Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science. 1980 Feb 1;207(4430):530–532. doi: 10.1126/science.7352262. [DOI] [PubMed] [Google Scholar]
  36. Schusdziarra V., Zyznar E., Rouiller D., Harris V., Unger R. H. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs. Endocrinology. 1980 Nov;107(5):1572–1576. doi: 10.1210/endo-107-5-1572. [DOI] [PubMed] [Google Scholar]
  37. Stoll R. W., Touber J. L., Menahan L. A., Williams R. H. Clearance of porcine insulin, proinsulin, and connecting peptide by the isolated rat liver. Proc Soc Exp Biol Med. 1970 Mar;133(3):894–896. doi: 10.3181/00379727-133-34589. [DOI] [PubMed] [Google Scholar]
  38. Terris S., Steiner D. F. Binding and degradation of 125I-insulin by rat hepatocytes. J Biol Chem. 1975 Nov 10;250(21):8389–8398. [PubMed] [Google Scholar]
  39. Terris S., Steiner D. F. Retention and degradation of 125I-insulin by perfused livers from diabetic rats. J Clin Invest. 1976 Apr;57(4):885–896. doi: 10.1172/JCI108365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Terry L. C., Crowley W. R. The effect of hypophysectomy on somatostatin-like immunoreactivity in discrete hypothalamic and extrahypothalamic nuclei. Endocrinology. 1980 Dec;107(6):1771–1775. doi: 10.1210/endo-107-6-1771. [DOI] [PubMed] [Google Scholar]
  41. Tydén G., Sammegård H., Thulin L., Friman L., Efendić S. Treatment of bleeding esophageal varices with somatostatin. N Engl J Med. 1978 Dec 28;299(26):1466–1467. doi: 10.1056/NEJM197812282992614. [DOI] [PubMed] [Google Scholar]
  42. UNGER R. H., EISENTRAUT A. M., McCALL M. S., MADISON L. L. Glucagon antibodies and an immunoassay for glucagon. J Clin Invest. 1961 Jul;40:1280–1289. doi: 10.1172/JCI104357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Unger R. H., Orci L. Possible roles of the pancreatic D-cell in the normal and diabetic states. Diabetes. 1977 Mar;26(3):241–244. doi: 10.2337/diab.26.3.241. [DOI] [PubMed] [Google Scholar]
  44. Vinicor F., Higdon G., Clark C. M., Jr Effects of somatostatin on the hepatic adenylate cyclase system in the rat. Endocrinology. 1977 Oct;101(4):1071–1077. doi: 10.1210/endo-101-4-1071. [DOI] [PubMed] [Google Scholar]
  45. Wass J. A., Penman E., Dryburgh J. R., Tsiolakis D., Goldberg P. L., Dawson A. M., Besser G. M., Rees L. H. Circulating somatostatin after food and glucose in man. Clin Endocrinol (Oxf) 1980 Jun;12(6):569–574. doi: 10.1111/j.1365-2265.1980.tb01377.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES